<DOC>
	<DOCNO>NCT02190084</DOCNO>
	<brief_summary>Alzheimer 's Dementia ( AD ) major public health problem . Apathy , profound loss motivation , see majority patient AD . Dysfunction front brain loss dopamine , type neurochemical , part brain result apathy . Presence apathy link deficit plan sequential task keep routine . Patients apathy poor physical function caregiver experience extra burden . Unfortunately good medication treat apathy . FDA approve use brain stimulation magnet know repetitive transcranial magnetic stimulation ( rTMS ) , treatment depression . rTMS increase dopamine apply frontal lobe brain propose rTMS would good treatment option apathy AD . Study hypotheses include rTMS dorsolateral prefrontal cortex ( DLPFC ) improve apathy executive function well sham treatment AD .</brief_summary>
	<brief_title>Repetitive Transcranial Magnetic Stimulation Apathy Alzheimer 's Dementia</brief_title>
	<detailed_description>Objective : Alzheimer 's Dementia ( AD ) major public health problem . Apathy , profound loss motivation , see majority patient AD . Dysfunction front brain loss dopamine , type neurochemical , part brain result apathy . Presence apathy link deficit plan sequential task keep routine . Patients apathy poor physical function caregiver experience extra burden . Unfortunately good medication treat apathy . FDA approve use brain stimulation magnet know repetitive transcranial magnetic stimulation ( rTMS ) , treatment depression . rTMS increase dopamine apply frontal lobe brain propose rTMS would good treatment option apathy AD . Specific Aims : To determine efficacy rTMS dorsolateral prefrontal cortex ( DLPFC ) treat apathy mild AD comparison sham treatment . • To compare efficacy rTMS DLPFC executive function mild AD comparison sham treatment . Research Plan : Current study prospective randomize sham control study daily rTMS . Methods : Up 500 subject pre-screened enroll 100 subject screen randomize 50 subject analyze 20 completers . Subjects mild AD apathy randomly assign rTMS sham treatment consent . All subject test memory , behavioral problem , function caregiver burden . Apathy assess use Apathy Evaluation Scale . Memory , executive function , functional status caregiver burden assess . Subjects receive daily treatment 4 week either rTMS sham coil total 20 treatment . Neither subject investigator know treatment subject receiving . Testing repeated end 4 week 8 12 week treatment .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>1 . Subjects age ≥ 55 year , 2 . Diagnosis Alzheimer 's dementia meeting DSMIV TR criterion , 3 . Apathy Evaluation ScaleClinician ( AESC ) score ≥ 30 , 4 . Mini Mental Status Examination ( MMSE ) ≥ 18 , 5 . Subjects clear TMS adult safety scale ( TASS ) 6 . On stable dose antidepressant dementia medicine ( applicable ) least two month 1 . Subjects take medication know increase risk seizure 2012 Beers criterion : Bupropion , chlorpromazine , clozapine , maprotiline , olanzapine , thioridazine , thiothixene , tramadol . 2 . Subjects take medication know increase seizure threshold list Beers criterion opinion PI increase seizure threshold : tricyclic antidepressant , theophylline , methylphenidate , highdose thyroid supplementation . 3 . Subjects take ototoxic medication : Aminoglycosides , Cisplatin . 4 . Subjects current episode major depression 5 . History bipolar disorder 6 . Subjects history seizure first degree relative seizure disorder 7 . Subjects implanted device : wearable implantable cardioverter defibrillator , conductive , ferromagnetic , magnetic sensitive metal implant nonremovable within 30 cm treatment coil cochlear implant 8 . Subjects diagnosis current alcohol relate problem 9 . Subjects history stroke , aneurysm , cranial neurosurgery 10 . Any condition opinion study physician likely compromise ability safely participate study</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>91 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>apathy</keyword>
	<keyword>Alzheimer 's</keyword>
	<keyword>executive function</keyword>
</DOC>